The global thoracolumbar spine devices market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive with all players competing to gain a stronghold in the market. Worldwide growing obese population, surging prevalence of spinal cord injuries and chronic back pain, increasing inclination of patients and healthcare professionals towards adoption of minimally invasive (MI) techniques, and rising elderly population are some of the factors fueling the market growth. The manufacturers are competing based on cost, quality, and reliability. It is crucial for market participants to provide cost-efficient and high-quality products to sustain and prosper in an intensely competitive and growing market environment.
The growth of market vendors is dependent on market conditions, government support, and industry development. Therefore, manufacturers should focus on geographic expansions and product performance improvements. They should chiefly focus on the development of innovative products. Though multinational market players are spearheading the market, regional, and international market players with small market shares also have a noticeable presence. The international market players can expand their presence across the world through mergers and acquisitions made during the assessment period. It has also been predicted that development of the global economic scenario along with efforts to develop healthcare infrastructure in emerging countries is assisting in the market growth, thereby making it an ideal time for new products and to increase the global market share.
B. Braun Melsungen AG (B. Braun) provides its products to hospitals, surgical units, private practices, and extracorporeal blood treatments. The company operates through four major divisions, such as hospital care, Aesculap, outpatient market, and B. Braun Avitum. With these four divisions, it has a wide range of products with about 5,000 products, out of which it manufactures 95% of the products. Geographically it operates in 64 countries in regions such as Europe, Asia-Pacific, Latin America, and the Middle East and Africa. B. Braun is focused on extending its product portfolio and increasing investment in research and development. The company emphasizes expanding geographically through partnerships with its customers to understand their needs and develop appropriate and innovative solutions.
Stryker Corporation (Stryker) is involved in developing, manufacturing, and marketing specialty surgical and medical products. The company's products include implants, biologics, surgical, neurologic, ear, and throat and interventional pain equipment, endoscopic, surgical navigation, communications, and digital imaging systems, along with patient handling and emergency medical equipment. It has classified its products into three major categories, namely, medical and surgical equipment, orthopedics, and neurotechnology. Stryker focuses on new product developments and on enhancing the customer experience and customer engagement. The company is more into acquisitions for developing a huge product line, capture the maximum market share, and to grow in the market successfully. The company focuses on acquisitions to address new sectors, maintaining the innovativeness of its products in all the segments.
Medtronic PLC (Medtronic) is a global healthcare solutions company committed to improving the lives of people through medical technologies, services, and solutions. The company has developed additional core technologies, including implantable mechanical devices, drugs and biologic delivery devices, and powered and advanced energy surgical instruments. These technologies are used to treat nearly 40 medical conditions. The company’s businesses majorly fall into four groups, namely, the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group, and the Minimally Invasive Therapies Group (MITG). Medtronic develops technologies and solutions in line with its mission to alleviate pain, restore health, and extend life for people. The company focuses on value-based healthcare principles to drive global growth. The company focuses on steady product launches to increase its product line and to improve clinical and economic outcomes across its therapeutic areas. It also focuses on expanding its presence in various regions through mergers and acquisitions.
DePuy Synthes is a part of the Johnson & Johnson family of companies. It offers the most comprehensive portfolio of spine, trauma, sports medicine, neuro, cranio-maxillofacial, power tools, and biomaterials. It is the second-largest spine company in the world. The company's leading solutions include comprehensive systems to treat spinal conditions ranging from scoliosis to degenerative disc disease. The company has a broad portfolio that supports nearly one million orthopedic and neuro procedures worldwide annually.
Zimmer Biomet Holdings, Inc. (Zimmer Biomet) develops, produces, and markets musculoskeletal healthcare products. It is a leading brand in providing customized joint and bone healthcare solutions. It provides products for joint reconstruction, dental reconstruction, sports medicine, and bone and skeletal repair. The company manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities, and trauma products, office-based technologies, spine, craniomaxillofacial and thoracic products, dental implants, and related surgical products. These products and solutions help to treat patients suffering from disorders, injuries, joints, and supporting soft tissues. Zimmer Biomet focuses on expanding the business by meeting the customers’ needs. The company also emphasizes optimizing manufacturing processes to maximize profits. It collaborates with healthcare professionals around the globe to advance the pace of innovation.
Some other participants present in the market are Orthofix Holdings, Inc., Alphatech Holdings, Inc., Exactech, Inc., Globus Medical Inc., and NuVasive Inc.
Bargaining Power of Suppliers
Bargaining power of suppliers in the global thoracolumbar spine devices market is low to moderate. The suppliers in the global thoracolumbar spine devices industry are medical device manufacturers. Currently, a high number of suppliers are present in the market due to high opportunities. Major players are accounting for a significant share of the market. Switching cost of the suppliers is moderate because suppliers tend to enter into long-term associations, partnership, and deals with the companies that sell thoracolumbar spine devices.
Bargaining Power of Buyers
The bargaining power of the buyers is moderate to high in the global thoracolumbar spine devices market due to the presence of many suppliers of thoracolumbar spine devices. The buyers of thoracolumbar spine devices are moderately inclined towards product manufacturers. The market consists of a high number of manufacturers which leads to many options with regards to product offering thus the bargaining power of buyers tends to be moderate to high in this market.
Threat of New Entrants
The threat of new entrants is low to moderate in the global thoracolumbar spine devices market. Any company trying to enter the thoracolumbar spine devices market is required to accept the regulatory standards and product should get approval by regulatory authorities. This market is also characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for new entrants. Moreover, products which are already available in the market are patented, and the cost involved in R&D is high, which creates unfavorable conditions for the new entrants in the market.
Threat of Substitutes
The threat of substitutes in the global thoracolumbar spine devices market is low. Substitutes pose a low threat in the global thoracolumbar spine devices market due to the unavailability of similar products which are offered by major market players. The major products used in thoracolumbar spine treatment are implants and instrumentation and spine biologics amongst others. Due to the availability of limited thoracolumbar spine devices, threat of substitutes in the global thoracolumbar spine devices market is low.
Intensity of Rivalry
The degree of competition in the global thoracolumbar spine devices market is high. Many manufacturers are present in the market. The market is shared by many major players, and their market share is fixed, which indicates the intense rivalry. Players are engaged in developing a process to lower their manufacturing cost to overcome the competition. Moreover, the players are also developing advanced techniques to differentiate their product from their rivals.
